Skip to content

Clinical pharmacology study of calcium alginate capsules -optimization study of inhibition of postprandial blood glucose level elevation-

Clinical pharmacology study of calcium alginate capsules -optimization study of inhibition of postprandial blood glucose level elevation- - Postprandial blood glucose elevation inhibitory effect optimization test of calcium alginate capsules

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048540
Enrollment
21
Registered
2022-08-10
Start date
2022-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Stage I: Placebo capsule Stage II: Test substance A capsule Stage III: Test substance B capsule Carbohydrate load: Udon noodles 180g After eating the carbohydrate load within 5 minutes, take the

Sponsors

Takasaki University of Health and Welfare
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Men and women who are 18 years of age or older at the time of obtaining consent 2.Persons who have fully understood and consented to the purpose and safety of this research specified in the Research Cooperation Consent Manual

Exclusion criteria

Exclusion criteria: 1.Persons whose BMI and body weight do not fit into the normal distribution (95% confidence interval) 2.Persons taking medicines or supplements that may affect glucose metabolism 3.Persons who are currently being treated for diabetes or who are judged to need treatment 4.Persons with serious diseases such as diabetes, liver disease, renal disease, hypertension, ischemic heart disease, digestive system disease, and those with a history of them 5.Persons who may cause allergic symptoms regarding udon noodles (flour, etc.)

Design outcomes

Primary

MeasureTime frame
The maximum blood concentration (Cmax) of the postprandial blood glucose The incremental area under the curve (IAUC) of the postprandial blood glucose The blood glucose level (before consumption of the carbohydrate load, 15,30,45,60,90 and 120 minutes after consumption of the carbohydrate load)

Countries

Japan

Contacts

Public ContactSatsuki Kimura

Takasaki University of Health and Welfare Faculty of Pharmacy

s-kimura@takasaki-u.ac.jp0273521180

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026